Within the constraints of an exploratory design, JTT was associated with a significant reduction in NK-cell CD95 in vivo and a selective attenuation of Fas-mediated apoptosis downstream of caspase-8 in T cells in vitro, without affecting intrinsic apoptosis or TRAIL-induced cancer-cell apoptosis. The gene discussed is FAS; the disease is cancer.